Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study (Q84874276)
Jump to navigation
Jump to search
scientific article published on 01 September 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study |
scientific article published on 01 September 2011 |
Statements
Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study (English)
Yoshiaki Furuya
Masataka Kuwana
1 September 2011